Skip to main content

Can physicians initiate conversations about aid in dying? Should they?





By Laura Petrillo, MD, @lpetrillz

As of today, it is legal for seriously ill patients in California to request lethal medication to end their lives from their physicians. That’s the verb that the End of Life Option Act uses, request.  One imagines a very determined patient, let’s call her Helen, asking her physician about something that’s been on her mind since she learned about her metastatic cancer: “Doctor, will you help me die?”  Maybe she saw Brittany Maynard on the cover of People magazine, or read about Jerry Brown’s opinion that it would be “a comfort” to have that option if he were dying and in pain. She is educated, like most of the people who use the Death with Dignity Act in Oregon, and eager to have control over the moment of her death. 

But what if Helen hadn’t read the news about the End of Life Option Act, and didn’t know that aid in dying was now legal in California? Imagine instead that she has just come to her follow-up appointment, nervously, to find out the results of her recent scans— and the results aren’t good. After her oncologist breaks the bad news, Helen asks, “What’s next?” The oncologist runs through the options of palliative chemotherapy, a clinical trial, or hospice when the time is right. He pauses. Now that it is legal in California, does he need to include aid in dying as one of the treatment options that he presents?  

Let’s first deal with the question of “can a physician bring up aid in dying?” Though the law requires that the patient has “voluntarily expressed the wish to receive a prescription for an aid-in-dying drug” in order for a physician to write a prescription, there is no clear requirement that a physician must wait for the patient to broach the subject. In the extreme, the law makes it a felony for anyone to knowingly coerce or exert undue influence on a person to consider aid in dying, but coercion is a high bar. So a well-meaning physician, who wants to ensure that his patients are making a fully informed decision, could put the option on the table, and as long as he doesn’t overtly browbeat the patient into making a formal request, he would be in the clear. Even if he were to be suggestive, and a family member or medical colleague brought the case to the attention of the Medical Board, the physician would only have to demonstrate that he was acting “in good faith” to avoid repercussions. 

Putting aside what’s legally permissible, perhaps the thornier question is, “should a physician bring up aid in dying?”  There has been an enormous shift over the last few decades to give patients more information and decision-making power, codified by the Patient Self Determination Act and evident in processes like informed consent. Some argue that patients like Helen, who has not heard of the End of Life Option Act but is eligible, should have the right to know her legal option of aid in dying and further, that it is the physician’s job to inform her.  Once she has all of the facts from the doctor, she can make a choice that matches her values. 

The only trouble with that concept is that the conveyance of information from physician to patient is never so purely technical and devoid of the physician’s values. Nor are patients and physicians on equal footing in terms of power. In choosing the moment to introduce the idea of aid in dying, the physician makes a value judgment that the patient may be at a point where they would consider that speeding up death is better than living. While some patients may feel comforted that their doctor is willing to talk about the subject, others may feel "a breach of trust, or abandonment,"* particularly those who already distrust the healthcare system.  Providers may unintentionally convey the message that the patient’s life is of diminishing value, or that the road ahead is so hard that the best treatment we have is death hastening. And though they may not even be aware, physicians may counsel patients differently based on implicit biases, and exert an influence over what patients choose by the order in which they present options. 

Chances are Helen read People magazine anyway… and if she were interested in aid in dying she could make her wishes known.  But if she didn’t, her oncologist should not presume that she shares his values and would welcome learning about aid in dying from him simply because she qualifies. 



*Dr. Alicia Fernandez, personal communication

Comments

Popular posts from this blog

Caring, and the Family Caregivers We Don’t See

Over lunch at a restaurant in Manhattan, my father and I talked about long-term care insurance and the emergence of senior centers and nursing homes across the U.S. that offer a variety of ethnic cuisines and cultural events, catering not only to a growing population of adults over 65, but also, to an increasingly diverse population of adults who call the U.S. their home. This conversation was different from many similar ones before it – we weren’t talking about my research; we were talking about our own lives.
My parents immigrated to the U.S. in the late ‘70s and early ‘80s, following their parents’ advice on professional opportunities that seemed unimaginable in India at the time. Although they considered moving back soon after to care for their aging parents and to raise children, they ultimately decided to stay in the U.S. As I chronicled earlier, my paternal grandparents lived with us until I completed middle school, at which point they returned to India and lived with my mater…

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…

Top 25 Studies in Hospice and Palliative Care (#HPMtop25)

by: Kara Bishoff (@kara_bischoff )

Back in 2015 we wrote a post asking for input on what articles should belong on a list of the top 25 articles in hospice and palliative care.   We decided to focus on hospice palliative care studies and trials - as opposed to review articles, consensus statements and opinion pieces.

Here’s what we came up with. It was hard to pick just 25! We highly prioritized clinical utility and tried to achieve diversity & balance. Many others are worthy of inclusion. Take a look and let us know if you have suggested changes for next year.

Module 1: Symptom Management
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients. Tarumi Y et al. JPSM, 2013.Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study. Currow DC et al. JPSM, 2011.Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomise…